| Diverse stimuli engage different neutrophil extracellular trap pathways EF Kenny, A Herzig, R Krüger, A Muth, S Mondal, PR Thompson, ... Elife 6, e24437, 2017 | 705 | 2017 |
| Drug repurposing: a promising tool to accelerate the drug discovery process V Parvathaneni, NS Kulkarni, A Muth, V Gupta Drug discovery today 24 (10), 2076-2085, 2019 | 376 | 2019 |
| Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix AE Yuzhalin, AN Gordon-Weeks, ML Tognoli, K Jones, B Markelc, ... Nature communications 9 (1), 4783, 2018 | 152 | 2018 |
| Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer B Vaidya, V Parvathaneni, NS Kulkarni, SK Shukla, JK Damon, A Sarode, ... International journal of biological macromolecules 122, 338-347, 2019 | 110 | 2019 |
| Disubstituted pyridines: The double-coupling approach ST Handy, T Wilson, A Muth The Journal of organic chemistry 72 (22), 8496-8500, 2007 | 101 | 2007 |
| Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα B Sun, N Dwivedi, TJ Bechtel, JL Paulsen, A Muth, M Bawadekar, G Li, ... Science immunology 2 (12), eaal3062, 2017 | 86 | 2017 |
| Development of glucose regulated protein 94-selective inhibitors based on the BnIm and radamide scaffold VM Crowley, A Khandelwal, S Mishra, AR Stothert, DJE Huard, J Zhao, ... Journal of medicinal chemistry 59 (7), 3471-3488, 2016 | 84 | 2016 |
| Polyamine transport inhibitors: design, synthesis, and combination therapies with difluoromethylornithine A Muth, M Madan, JJ Archer, N Ocampo, L Rodriguez, O Phanstiel IV Journal of medicinal chemistry 57 (2), 348-363, 2014 | 83 | 2014 |
| Development of a selective inhibitor of protein arginine deiminase 2 A Muth, V Subramanian, E Beaumont, M Nagar, P Kerry, P McEwan, ... Journal of medicinal chemistry 60 (7), 3198-3211, 2017 | 77 | 2017 |
| Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response F Ghari, AM Quirke, S Munro, J Kawalkowska, S Picaud, J McGouran, ... Science advances 2 (2), e1501257, 2016 | 76 | 2016 |
| Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning T Sherrin, T Blank, C Hippel, M Rayner, RJ Davis, C Todorovic Journal of Neuroscience 30 (40), 13348-13361, 2010 | 76 | 2010 |
| Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ... International Journal of Biological Macromolecules 164, 638-650, 2020 | 75 | 2020 |
| PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling H Qin, X Liu, F Li, L Miao, T Li, B Xu, X An, A Muth, PR Thompson, ... Cancer letters 409, 30-41, 2017 | 68 | 2017 |
| Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer SK Shukla, NS Kulkarni, A Chan, V Parvathaneni, P Farrales, A Muth, ... Pharmaceutics 11 (11), 559, 2019 | 66 | 2019 |
| Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ... Pharmaceutics 12 (3), 206, 2020 | 62 | 2020 |
| Polypharmacology: The science of multi-targeting molecules A Kabir, A Muth Pharmacological Research 176, 106055, 2022 | 61 | 2022 |
| Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability B Vaidya, SK Shukla, S Kolluru, M Huen, N Mulla, N Mehra, D Kanabar, ... Carbohydrate polymers 204, 68-77, 2019 | 55 | 2019 |
| Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ... Pharmaceutical research 37, 1-19, 2020 | 54 | 2020 |
| Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ... European Journal of Pharmaceutical Sciences 133, 145-159, 2019 | 54 | 2019 |
| Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis NS Kulkarni, Y Guererro, N Gupta, A Muth, V Gupta Journal of drug delivery science and technology 49, 352-364, 2019 | 54 | 2019 |
